Screening Tool Artificial intelligence-based for predicting the genetic Risk of BREAST cancer

Trial Identifier:	D0817R00113
Sponsor:	AstraZeneca
Start Date:	September 2025
Primary Completion Date:	August 2026
Study Completion Date:	August 2026
Condition:	Breast Cancer

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Brazil, GO	Goiânia, GO, Brazil
Brazil, RS	Porto Alegre, RS, Brazil, 90560-032

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.